					<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-14.2.1'-->
<!--Jetpack_Sitemap_Buffer_News-->
<?xml-stylesheet type="text/xsl" href="//bioutah.org/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://bioutah.org/co-diagnostics-invited-to-participate-in-npoc-tuberculosis-diagnostics-workshop-in-bangkok-thailand/</loc><lastmod>2026-07-10T02:33:31Z</lastmod><news:news><news:publication><news:name>BioUtah</news:name><news:language>en</news:language></news:publication><news:title>Co-Diagnostics Invited to Participate in NPOC Tuberculosis Diagnostics Workshop in Bangkok, Thailand</news:title><news:publication_date>2026-07-10T02:33:31Z</news:publication_date><news:genres>Blog</news:genres></news:news></url><url><loc>https://bioutah.org/fda-accepts-snda-for-roflumilast-cream-0-05-in-infants-with-atopic-dermatitis-down-to-3-months/</loc><lastmod>2026-07-10T01:54:46Z</lastmod><news:news><news:publication><news:name>BioUtah</news:name><news:language>en</news:language></news:publication><news:title>FDA Accepts sNDA for Roflumilast Cream 0.05% in Infants With Atopic Dermatitis Down to 3 Months</news:title><news:publication_date>2026-07-10T01:54:46Z</news:publication_date><news:genres>Blog</news:genres></news:news></url><url><loc>https://bioutah.org/denali-therapeutics-to-give-opening-plenary-address-at-alzheimers-association-international-conference-aaic-2026-and-highlight-breakthroughs-in-delivering-biologic-therapies-across-blood-br/</loc><lastmod>2026-07-10T01:52:14Z</lastmod><news:news><news:publication><news:name>BioUtah</news:name><news:language>en</news:language></news:publication><news:title>Denali Therapeutics to Give Opening Plenary Address at Alzheimer’s Association International Conference (AAIC) 2026 and Highlight Breakthroughs in Delivering Biologic Therapies Across Blood-Brain Barrier</news:title><news:publication_date>2026-07-10T01:52:14Z</news:publication_date><news:genres>Blog</news:genres></news:news></url><url><loc>https://bioutah.org/rep-mike-kennedy-visits-edwards-lifesciences/</loc><lastmod>2026-07-10T02:06:09Z</lastmod><news:news><news:publication><news:name>BioUtah</news:name><news:language>en</news:language></news:publication><news:title>Rep. Mike Kennedy Visits Edwards Lifesciences</news:title><news:publication_date>2026-07-09T20:00:39Z</news:publication_date><news:genres>Blog</news:genres></news:news></url><url><loc>https://bioutah.org/pdv-medtech-and-corscience-announce-strategic-partnership-to-advance-medtech-development-and-manufacturing-across-the-us-and-europe/</loc><lastmod>2026-07-09T16:41:17Z</lastmod><news:news><news:publication><news:name>BioUtah</news:name><news:language>en</news:language></news:publication><news:title>PDV MedTech and Corscience Announce Strategic Partnership to Advance MedTech Development and Manufacturing Across the US and Europe</news:title><news:publication_date>2026-07-09T16:41:17Z</news:publication_date><news:genres>Blog</news:genres></news:news></url></urlset>
